CABTREO
CABTREO
Approved
DIN Number
02550423
Drug Class
Human
Market Date
Oct 7, 2024
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02550423
AIG Number0366104001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D10AF51 CLINDAMYCIN, COMBINATIONS
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:04.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
ADAPALENEActive
Strength: 0.15 % / W/W
Monograph: ADAPALENE
BENZOYL PEROXIDEActive
Strength: 3.1 % / W/W
Monograph: BENZOYL PEROXIDE
CLINDAMYCIN PHOSPHATEActive
Strength: 1.2 % / W/W
Monograph: CLINDAMYCIN PHOSPHATE